SCHEMBL722134

SCHEMBL722134

CCOP(=O)(OCC)C(Cc1ccc(F)cc1)c1sc2ccccc2c1Br

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.56
PTGS2 P35354 4/20 0.42
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.37
ALDH1A1 P00352 1/20 0.36
PTPN1 P18031 1/20 0.35
LMNA P02545 2/20 0.34
TP53 P04637 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
CYP2D6 P10635 1/20 0.34
CHRM1 P11229 1/20 0.34
HTR2A P28223 1/20 0.34
HRH1 P35367 1/20 0.34
POLB P06746 1/20 0.33
CASP3 P42574 2/20 0.33
GAA P10253 1/20 0.33
CASP7 P55210 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL716712 0.89 TRPM8 (0.44) TRPM8PTGS2KDM4EMAPTALDH1A1
SCHEMBL5051478 0.88 TRPM8 (0.63) TRPM8PTGS2KDM4ELMNAMEN1
SCHEMBL718483 0.87 TRPM8 (0.72) TRPM8PTGS2KDM4EMAPTPTPN1
SCHEMBL717007 0.87 TRPM8 (0.72) TRPM8PTGS2KDM4EMAPTPTPN1
SCHEMBL718589 0.86 TRPM8 (0.54) TRPM8KDM4EALDH1A1LMNACYP2D6
SCHEMBL717136 0.86 TRPM8 (0.60) TRPM8PTGS2MAPTPTPN1MEN1
SCHEMBL10247212 0.85 TRPM8 (0.59) TRPM8PTGS2MAPTLMNAGAA
SCHEMBL717608 0.84 TRPM8 (0.53) TRPM8PTGS2MAPTALDH1A1LMNA
SCHEMBL715489 0.82 TRPM8 (0.51) TRPM8PTGS2KDM4EMAPTALDH1A1
SCHEMBL717280 0.82 TRPM8 (0.53) TRPM8PTGS2KDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9090639-B2 Cold menthol receptor-1 antagonists JANSSEN PHARMACEUTICA N.V. (BE) 2015-07-28 US disclosed
US-20140100194-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS JANSSEN PHARMACEUTICA, NV (BE) 2014-04-10 US disclosed
US-8629281-B2 Cold menthol receptor-1 antagonists JANSSEN PHARMACEUTICA, NV (BE) 2014-01-14 US disclosed
US-8558011-B2 Cold menthol receptor-1 antagonists JANSSEN PHARMACEUTICA, NV (BE) 2013-10-15 US disclosed
EP-2029614-B1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2013-01-23 EP disclosed
US-20120184510-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS COLBURN RAYMOND W (US) 2012-07-19 US disclosed
US-20120053347-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2012-03-01 US disclosed
US-7897781-B2 Cold menthol receptor-1 antagonists JANSSEN PHARMACEUTICA NV (BE) 2011-03-01 US disclosed
US-20080287398-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2008-11-20 US disclosed
US-20080027029-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2008-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027029-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS TRPM8, TRPM5, TRPM7 TRPM8 1/4885PTGS2 909/4885KDM4E 2229/4885
US-20120184510-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS TRPM8, TRPM5, TRPM7 TRPM8 1/4885PTGS2 909/4885KDM4E 2229/4885
US-20120053347-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS TRPM8, TRPM5, TRPM7 TRPM8 1/4885PTGS2 909/4885KDM4E 2229/4885
US-20080287398-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS TRPM8, TRPM5, TRPM7 TRPM8 1/4885PTGS2 909/4885KDM4E 2229/4885
US-20140100194-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS TRPM8, TRPM5, TRPM7 TRPM8 1/4885PTGS2 909/4885KDM4E 2229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.